{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:18:35Z","timestamp":1788985115921,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03507-2","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:36:11Z","timestamp":1788978971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Direct Powder Extrusion of Atorvastatin 3D-Printed Tablets for Immediate-Release: Solid-State Characterization and Dissolution Performance"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6671-1188","authenticated-orcid":false,"given":"Thirupathi Reddy","family":"Anekalla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8987-3870","authenticated-orcid":false,"given":"Sujith Raj","family":"Bashetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1887-2999","authenticated-orcid":false,"given":"Navya","family":"Nalajala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1324-3661","authenticated-orcid":false,"given":"Nagarjuna","family":"Narala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9243-5101","authenticated-orcid":false,"given":"Tejaswi","family":"Appidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0039-0064","authenticated-orcid":false,"given":"LR Jaidev","family":"Chakka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3373-5586","authenticated-orcid":false,"given":"Mohammed","family":"Maniruzzaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"issue":"11","key":"3507_CR1","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/eurjpc\/zwae281","volume":"32","author":"B Chong","year":"2025","unstructured":"Chong B, Jayabaskaran J, Jauhari SM, Chan SP, Goh R, Kueh MTW, et al. Global burden of cardiovascular diseases: projections from 2025 to 2050. Eur J Prev Cardiol. 2025;32(11):1001\u201315.","journal-title":"Eur J Prev Cardiol"},{"key":"3507_CR2","doi-asserted-by":"crossref","unstructured":"Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators. Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023.\u00a0J Am Coll Cardiol. 2025;86(22):2167-243.","DOI":"10.1016\/j.jacc.2025.08.015"},{"key":"3507_CR3","first-page":"200212","volume":"19","author":"H Lababidi","year":"2023","unstructured":"Lababidi H, Salerno PR, Wass SY, ShafiabadiHasani N, Bourges-Sevenier B, Al-Kindi S. The Global Burden of premature cardiovascular disease, 1990\u20132019. Int J Cardiol Cardiovasc Risk. 2023;19:200212.","journal-title":"Int J Cardiol Cardiovasc Risk"},{"issue":"3","key":"3507_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jacc.2025.04.043","volume":"86","author":"DA Watkins","year":"2025","unstructured":"Watkins DA, Pickersgill SJ, Flood D, Gaziano TA, Huffman MD, Islam S, et al. Global Impact of Fixed-Dose Combination Therapies on Cardiovascular Mortality and Events, 2023\u20132050: A Modeling Study. J Am Coll Cardiol. 2025;86(3):149\u201361.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"3507_CR5","doi-asserted-by":"publisher","first-page":"e0319991","DOI":"10.1371\/journal.pone.0319991","volume":"20","author":"M Su","year":"2025","unstructured":"Su M, Qin XS, Li Y, Upshur R, Sullivan F, L\u00e9gar\u00e9 F, et al. Association between medication adherence and cardiovascular outcomes in patients with both diabetes and hypertension in primary care settings in Canada: A retrospective cohort study. PLoS ONE. 2025;20(4):e0319991.","journal-title":"PLoS ONE"},{"key":"3507_CR6","doi-asserted-by":"publisher","first-page":"1564791","DOI":"10.3389\/fmed.2025.1564791","volume":"12","author":"HJ Kim","year":"2025","unstructured":"Kim HJ, Kim BS, Kim H, Lee J, Shin JH, Sung KC. Impact of blood pressure and medication adherence on clinical outcomes in patients with hypertension. Front Med. 2025;12:1564791.","journal-title":"Front Med"},{"key":"3507_CR7","unstructured":"Epilepsy Foundation. The first FDA approved drug made by a 3D printer is levetiracetam.( August 2015). Available from: https:\/\/www.epilepsy.com\/stories\/first-fda-approved-drug-made-3d-printer-levetiracetam.\u00a0Accessed 19 Jan 2026."},{"issue":"1","key":"3507_CR8","first-page":"1","volume":"3","author":"LRJ Chakka","year":"2025","unstructured":"Chakka LRJ, Chede LS, Bashetty SR, Maniruzzaman M. Functional scaffolds and methods for bone tissue engineering applications. Biofunctional Materials. 2025;3(1):1\u201316.","journal-title":"Biofunctional Materials"},{"issue":"6","key":"3507_CR9","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.37349\/emed.2023.00200","volume":"4","author":"K Pathak","year":"2023","unstructured":"Pathak K, Saikia R, Das A, Das D, Islam MA, Pramanik P, et al. 3D printing in biomedicine: advancing personalized care through additive manufacturing. Explor Med. 2023;4(6):1135\u201367.","journal-title":"Explor Med"},{"issue":"6","key":"3507_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.tips.2023.03.006","volume":"44","author":"AK J\u00f8rgensen","year":"2023","unstructured":"J\u00f8rgensen AK, Ong JJ, Parhizkar M, Goyanes A, Basit AW. Advancing non-destructive analysis of 3D printed medicines. Trends Pharmacol Sci. 2023;44(6):379\u201393.","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"3507_CR11","first-page":"88","volume":"13","author":"A Mihaylova","year":"2025","unstructured":"Mihaylova A, Yaneva A, Shopova D, Kasnakova P, Harizanova S, Parahuleva N, et al. Pharmacists\u2019 Perceptions of 3D Printing and Bioprinting as Part of Personalized Pharmacy: A Cross-Sectional Pilot Study in Bulgaria. Pharmacy (Basel). 2025;13(3):88.","journal-title":"Pharmacy (Basel)"},{"issue":"4","key":"3507_CR12","doi-asserted-by":"publisher","first-page":"622","DOI":"10.18063\/ijb.v8i4.622","volume":"8","author":"J Mancilla-De-la-Cruz","year":"2022","unstructured":"Mancilla-De-la-Cruz J, Rodriguez-Salvador M, An J, Chua CK. Three-Dimensional Printing Technologies for Drug Delivery Applications: Processes, Materials, and Effects. Int J Bioprint. 2022;8(4):622.","journal-title":"Int J Bioprint"},{"key":"3507_CR13","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jconrel.2022.09.032","volume":"351","author":"L Krueger","year":"2022","unstructured":"Krueger L, Miles JA, Popat A. 3D printing hybrid materials using fused deposition modelling for solid oral dosage forms. J Control Release. 2022;351:444\u201355.","journal-title":"J Control Release"},{"key":"3507_CR14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.addr.2021.02.006","volume":"172","author":"S Bandari","year":"2021","unstructured":"Bandari S, Nyavanandi D, Dumpa N, Repka MA. Coupling hot melt extrusion and fused deposition modeling: Critical properties for successful performance. Adv Drug Deliv Rev. 2021;172:52\u201363.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"3507_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2217\/3dp-2021-0031","volume":"6","author":"U Bhatt","year":"2022","unstructured":"Bhatt U, Sharma PK, Murty US, Banerjee S. Systematic evaluations of melt-extruded filament for fused deposition modeling-mediated 3D printing. J 3D Print Med. 2022;6(2):77\u201394.","journal-title":"J 3D Print Med"},{"issue":"9","key":"3507_CR16","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s11095-018-2454-x","volume":"35","author":"W Jamr\u00f3z","year":"2018","unstructured":"Jamr\u00f3z W, Szafraniec J, Kurek M, Jachowicz R. 3D Printing in Pharmaceutical and Medical Applications - Recent Achievements and Challenges. Pharm Res. 2018;35(9):176.","journal-title":"Pharm Res"},{"key":"3507_CR17","doi-asserted-by":"publisher","first-page":"120501","DOI":"10.1016\/j.ijpharm.2021.120501","volume":"600","author":"N Dumpa","year":"2021","unstructured":"Dumpa N, Butreddy A, Wang H, Komanduri N, Bandari S, Repka MA. 3D printing in personalized drug delivery: An overview of hot-melt extrusion-based fused deposition modeling. Int J Pharm. 2021;600:120501.","journal-title":"Int J Pharm"},{"issue":"4","key":"3507_CR18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/pharmaceutics16040437","volume":"16","author":"\u00c1 Aguilar-de-Leyva","year":"2024","unstructured":"Aguilar-de-Leyva \u00c1, Casas M, Ferrero C, Linares V, Caraballo I, Aguilar-de-Leyva \u00c1, et al. 3D Printing Direct Powder Extrusion in the Production of Drug Delivery Systems: State of the Art and Future Perspectives. Pharmaceutics. 2024;16(4):437.","journal-title":"Pharmaceutics"},{"key":"3507_CR19","doi-asserted-by":"publisher","first-page":"125542","DOI":"10.1016\/j.ijpharm.2025.125542","volume":"675","author":"C Fratini","year":"2025","unstructured":"Fratini C, Moroni S, Angelis DD, Tiboni M, Balducci AG, Rossi A, et al. Direct powder extrusion (DPE) 3D-printing of mini-tablets for preclinical studies in rodents. Int J Pharm. 2025;675:125542.","journal-title":"Int J Pharm"},{"issue":"10","key":"3507_CR20","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.3390\/pharmaceutics13101583","volume":"13","author":"SA S\u00e1nchez-Guirales","year":"2021","unstructured":"S\u00e1nchez-Guirales SA, Jurado N, Kara A, Lalatsa A, Serrano DR, S\u00e1nchez-Guirales SA, et al. Understanding Direct Powder Extrusion for Fabrication of 3D Printed Personalised Medicines: A Case Study for Nifedipine Minitablets. Pharmaceutics. 2021;13(10):1583.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3507_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1208\/s12249-015-0360-7","volume":"17","author":"H Patil","year":"2015","unstructured":"Patil H, Tiwari RV, Repka MA. Hot-Melt Extrusion: from Theory to Application in Pharmaceutical Formulation. AAPS PharmSciTech. 2015;17(1):20\u201342.","journal-title":"AAPS PharmSciTech"},{"issue":"1\u20132","key":"3507_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ijpharm.2012.11.048","volume":"443","author":"M Maniruzzaman","year":"2013","unstructured":"Maniruzzaman M, Morgan DJ, Mendham AP, Pang J, Snowden MJ, Douroumis D. Drug-polymer intermolecular interactions in hot-melt extruded solid dispersions. Int J Pharm. 2013;443(1\u20132):199\u2013208.","journal-title":"Int J Pharm"},{"key":"3507_CR23","doi-asserted-by":"publisher","first-page":"118471","DOI":"10.1016\/j.ijpharm.2019.118471","volume":"567","author":"A Goyanes","year":"2019","unstructured":"Goyanes A, Allahham N, Trenfield SJ, Stoyanov E, Gaisford S, Basit AW. Direct powder extrusion 3D printing: Fabrication of drug products using a novel single-step process. Int J Pharm. 2019;567:118471.","journal-title":"Int J Pharm"},{"key":"3507_CR24","doi-asserted-by":"publisher","first-page":"119560","DOI":"10.1016\/j.ijpharm.2020.119560","volume":"586","author":"P Pandi","year":"2020","unstructured":"Pandi P, Bulusu R, Kommineni N, Khan W, Singh M. Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products. Int J Pharm. 2020;586:119560.","journal-title":"Int J Pharm"},{"issue":"8","key":"3507_CR25","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1016\/j.apsb.2021.05.014","volume":"11","author":"SV Bhujbal","year":"2021","unstructured":"Bhujbal SV, Mitra B, Jain U, Gong Y, Agrawal A, Karki S, et al. Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies. Acta Pharmaceutica Sinica B. 2021;11(8):2505\u201336.","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"3507_CR26","unstructured":"U.S. Food and Drug Administration (2009) Lipitor (atorvastatin calcium) tablets, for oral use: full prescribing information. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/020702s057lbl.pdf. Accessed 15 Jan 2026."},{"issue":"11","key":"3507_CR27","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.3390\/pharmaceutics14112488","volume":"14","author":"T Pflieger","year":"2022","unstructured":"Pflieger T, Venkatesh R, Dachtler M, Eggenreich K, Laufer S, Lunter D, et al. Novel Approach to Pharmaceutical 3D-Printing Omitting the Need for Filament\u2014Investigation of Materials, Process, and Product Characteristics. Pharmaceutics. 2022;14(11):2488.","journal-title":"Pharmaceutics"},{"key":"3507_CR28","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jconrel.2017.11.022","volume":"269","author":"M Sadia","year":"2018","unstructured":"Sadia M, Arafat B, Ahmed W, Forbes RT, Alhnan MA. Channelled tablets: An innovative approach to accelerating drug release from 3D printed tablets. J Control Release. 2018;269:355\u201363.","journal-title":"J Control Release"},{"key":"3507_CR29","first-page":"101136","volume":"14","author":"N Narala","year":"2026","unstructured":"Narala N, Munnangi S, Baisa S, Lakkala P, Uttreja P, Karnik I, et al. Lactose based crystalline solid dispersions to enhance ibuprofen solubility via hot-melt extrusion: A design of experiments approach. Carbohydr Polym Technol Appl. 2026;14:101136.","journal-title":"Carbohydr Polym Technol Appl"},{"key":"3507_CR30","doi-asserted-by":"publisher","first-page":"104384","DOI":"10.1016\/j.jddst.2023.104384","volume":"82","author":"S Narala","year":"2023","unstructured":"Narala S, Komanduri N, Nyavanandi D, Youssef AAA, Mandati P, Alzahrani A, et al. Hard Gelatin Capsules Containing Hot Melt Extruded Solid Crystal Suspension of Carbamazepine for improving dissolution: Preparation and In vitro Evaluation. J Drug Deliv Sci Technol. 2023;82:104384.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3507_CR31","volume":"15","author":"SR Bashetty","year":"2026","unstructured":"Bashetty SR, Zhang Y, Nalajala N, Anekalla TR, Gudipati LP, Narala N, Alluri R, Maniruzzaman M. Eco-Friendly Selective Laser Sintered (SLS) 3D Printing of Tablets Using Starch 1500\u00ae as a Standalone Green Excipient. Carbohydr Polym Technol Appl. 2026;15: 101153.","journal-title":"Carbohydr Polym Technol Appl"},{"issue":"4","key":"3507_CR32","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.talanta.2007.07.030","volume":"74","author":"D Skorda","year":"2008","unstructured":"Skorda D, Kontoyannis CG. Identification and quantitative determination of atorvastatin calcium polymorph in tablets using FT-Raman spectroscopy. Talanta. 2008;74(4):1066\u201370.","journal-title":"Talanta"},{"issue":"1","key":"3507_CR33","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.xphs.2017.10.021","volume":"107","author":"NG Solanki","year":"2018","unstructured":"Solanki NG, Tahsin M, Shah AV, Serajuddin ATM. Formulation of 3D printed tablet for rapid drug release by fused deposition modeling: screening polymers for drug release, drug-polymer miscibility and printability. J Pharm Sci. 2018;107(1):390\u2013401.","journal-title":"J Pharm Sci"},{"key":"3507_CR34","unstructured":"United States Pharmacopeia (USP) (2025) Atorvastatin calcium. Available from: https:\/\/doi.usp.org\/USPNF\/USPNF_M6339_09_01. Accessed 12 Jan 2026."},{"key":"3507_CR35","unstructured":"Agnitio Inc. (2022) Atorvastatin calcium-atorvastatin calcium tablets. DailyMed. Available from: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=dcfc263d-9a3a-48a3-ad17-0e0dcd3a50f5.\u00a0Accessed 14 Jan 2026."},{"key":"3507_CR36","unstructured":"Fanous M. Three-dimensional Printing of Tablets: A Potential Approach to On-clinical-site Extemporaneous Formulation and Personalized Medicine (Doctoral dissertation, Philosophisch-Naturwissenschaftliche Fakult\u00e4t der Universit\u00e4t Basel)."},{"key":"3507_CR37","doi-asserted-by":"publisher","first-page":"120417","DOI":"10.1016\/j.ijpharm.2021.120417","volume":"599","author":"M Fanous","year":"2021","unstructured":"Fanous M, Bitar M, Gold S, Sobczuk A, Hirsch S, Ogorka J, et al. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution. Int J Pharm. 2021;599:120417.","journal-title":"Int J Pharm"},{"key":"3507_CR38","doi-asserted-by":"publisher","first-page":"123218","DOI":"10.1016\/j.ijpharm.2023.123218","volume":"643","author":"M Rosch","year":"2023","unstructured":"Rosch M, Gutowski T, Baehr M, Eggert J, Gottfried K, Gundler C, et al. Development of an immediate release excipient composition for 3D printing via direct powder extrusion in a hospital. Int J Pharm. 2023;643:123218.","journal-title":"Int J Pharm"},{"key":"3507_CR39","doi-asserted-by":"publisher","first-page":"105394","DOI":"10.1016\/j.jddst.2024.105394","volume":"92","author":"J Krause","year":"2024","unstructured":"Krause J, Domsta V, Ulbricht M, Schick P, Seidlitz A. A case study to investigate the influence of extrusion temperature, 3D printing parameters and the use of antioxidants on the degradation of dexamethasone. J Drug Deliv Sci Technol. 2024;92:105394.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"4","key":"3507_CR40","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3390\/bioengineering10040402","volume":"10","author":"F Wang","year":"2023","unstructured":"Wang F, Li L, Zhu X, Chen F, Han X. Development of pH-responsive polypills via semi-solid extrusion 3D printing. Bioengineering. 2023;10(4):402.","journal-title":"Bioengineering."},{"key":"3507_CR41","doi-asserted-by":"publisher","unstructured":"Ozon E, Musuc AM, S\u00e2rbu I, Popovici V, Pop A, Lupuleasa D. Parametric Optimization in 3D Printed Tablets Using Statistical Methods of Experimental Design. 2023. https:\/\/doi.org\/10.20944\/preprints202306.0136.v1","DOI":"10.20944\/preprints202306.0136.v1"},{"issue":"6","key":"3507_CR42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12247-024-09878-y","volume":"19","author":"A Bhatkande","year":"2024","unstructured":"Bhatkande A, Narala S, Wang H, Narala N, Karnik I, Vemula SK, et al. Extrusion-Based Three-Dimensional Printing of Metronidazole Immediate Release Tablets: Impact of Processing Parameters and in Vitro Evaluation. J Pharm Innov. 2024;19(6):72.","journal-title":"J Pharm Innov"},{"issue":"1","key":"3507_CR43","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.ijpharm.2016.09.050","volume":"513","author":"M Sadia","year":"2016","unstructured":"Sadia M, So\u015bnicka A, Arafat B, Isreb A, Ahmed W, Kelarakis A, et al. Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets. Int J Pharm. 2016;513(1):659\u201368.","journal-title":"Int J Pharm"},{"issue":"2","key":"3507_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0317407","volume":"20","author":"KA Salazar-Barrantes","year":"2025","unstructured":"Salazar-Barrantes KA, Abdala-Saiz A, Vega-Baudrit JR, Navarro-Hoyos M, Araya-Sibaja AM. Formulation and evaluation of atorvastatin calcium trihydrate Form I tablets. PLoS One. 2025;20(2): e0317407.","journal-title":"PLoS One."},{"issue":"3","key":"3507_CR45","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3390\/pharmaceutics16030324","volume":"16","author":"P Uttreja","year":"2024","unstructured":"Uttreja P, Youssef AAA, Karnik I, Sanil K, Narala N, Wang H, et al. Formulation Development of Solid Self-Nanoemulsifying Drug Delivery Systems of Quetiapine Fumarate via Hot-Melt Extrusion Technology: Optimization Using Central Composite Design. Pharmaceutics. 2024;16(3):324.","journal-title":"Pharmaceutics"},{"issue":"2","key":"3507_CR46","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/pharmaceutics12020124","volume":"12","author":"MA Azad","year":"2020","unstructured":"Azad MA, Olawuni D, Kimbell G, Badruddoza AZM, Hossain MS, Sultana T. Polymers for extrusion-based 3D printing of pharmaceuticals: a holistic materials\u2013process perspective. Pharmaceutics. 2020;12(2):124.","journal-title":"Pharmaceutics"},{"key":"3507_CR47","unstructured":"NuCare Pharmaceuticals, Inc. (2026) Atorvastatin calcium-atorvastatin calcium tablet, film coated. DailyMed. Available from: https:\/\/dailymed.nlm.nih.gov\/dailymed\/lookup.cfm?setid=4847b761-30a5-0a1a-e063-6294a90ad02b&version=1.\u00a0Accessed 19 Jan 2026."},{"issue":"1\u20133","key":"3507_CR48","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/20468954.2024.2389774","volume":"13","author":"A Sharma","year":"2024","unstructured":"Sharma A, Rathi R, Sharma S, Sangnim T, Huanbutta K, Singh I. 3D-printed immediate release solid dosage forms: a patent evaluation of US11622940B2. Pharm Pat Anal. 2024;13(1\u20133):45\u201351.","journal-title":"Pharm Pat Anal"},{"key":"3507_CR49","doi-asserted-by":"publisher","first-page":"122444","DOI":"10.1016\/j.ijpharm.2022.122444","volume":"630","author":"J Pyteraf","year":"2023","unstructured":"Pyteraf J, Jamr\u00f3z W, Kurek M, B\u0105k U, Loskot J, Kramarczyk D, et al. Preparation and advanced characterization of highly drug-loaded, 3D printed orodispersible tablets containing fluconazole. Int J Pharm. 2023;630:122444.","journal-title":"Int J Pharm"},{"issue":"9","key":"3507_CR50","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.3390\/polym12091872","volume":"12","author":"R Thakkar","year":"2020","unstructured":"Thakkar R, Pillai AR, Zhang J, Zhang Y, Kulkarni V, Maniruzzaman M. Novel on-demand 3-dimensional (3-D) printed tablets using fill density as an effective release-controlling tool. Polymers (Basel). 2020;12(9):1872.","journal-title":"Polymers (Basel)"},{"issue":"10","key":"3507_CR51","doi-asserted-by":"publisher","first-page":"103943","DOI":"10.1016\/j.xphs.2025.103943","volume":"114","author":"K Garba-Mohammed","year":"2025","unstructured":"Garba-Mohammed K, Bendicho-Lavilla C, Worsley A, Bonelli A, Haggan G, Hughes C, et al. 3D printing of dose-flexible crystalline solid dispersion tablets suitable for preclinical and first-in-human studies. J Pharm Sci. 2025;114(10):103943.","journal-title":"J Pharm Sci"},{"issue":"12","key":"3507_CR52","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1016\/j.xphs.2019.09.014","volume":"108","author":"NG Solanki","year":"2019","unstructured":"Solanki NG, Kathawala M, Serajuddin ATM. Effects of Surfactants on Itraconazole-Hydroxypropyl Methylcellulose Acetate Succinate Solid Dispersion Prepared by Hot Melt Extrusion III: Tableting of Extrudates and Drug Release From Tablets. J Pharm Sci. 2019;108(12):3859\u201369.","journal-title":"J Pharm Sci"},{"issue":"2","key":"3507_CR53","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","volume":"13","author":"P Costa","year":"2001","unstructured":"Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123\u201333.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"3507_CR54","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0378-5173(83)90064-9","volume":"15","author":"RW Korsmeyer","year":"1983","unstructured":"Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15(1):25\u201335.","journal-title":"Int J Pharm"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03507-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03507-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03507-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:03:22Z","timestamp":1788984202000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03507-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":54,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3507"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03507-2","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Mohammed Maniruzzaman holds stock in, serves on a scientific advisory board for, or is a consultant for CoM3D (Surrey, UK), DosePlus Therapeutics (Princeton, NJ, USA), Septum Solutions (Houston, TX, USA), and SmarGic Tech LLC (Oxford, MS, USA). The companies had no role in the design of the study, in the collection, analysis, or interpretation of data. L.R. Jaidev Chakka holds stock in SmarGic Tech LLC.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"287"}}